AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE

उत्पाद अवलोकन

About AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE

AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE is a medication used in the treatment of HIV-1 infection. It is a combination of two active ingredients, Emtricitabine and Tenofovir Disoproxil Fumarate, which work together to help control the virus. This medication is typically prescribed as part of antiretroviral therapy and is essential for managing the condition and preventing its progression.

Key Benefits & Uses

• Treatment of HIV-1 infection in adults and pediatric patients
• Prevention of HIV-1 infection in individuals at high risk
• Part of antiretroviral therapy to control the virus and manage the condition

Active Ingredient & Action

Emtricitabine and Tenofovir Disoproxil Fumarate, the active ingredients in AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE, are nucleoside and nucleotide reverse transcriptase inhibitors, respectively. They work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of the HIV-1 virus. By blocking this enzyme, AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE helps to reduce the amount of virus in the body and slow down the progression of the disease.

Important Notes

It is essential to take AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE exactly as prescribed by your healthcare provider. Patients should also be aware of potential side effects and report any changes in their condition to their doctor. Regular monitoring of kidney function and bone density is recommended, as this medication may affect these areas. Additionally, AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE should not be used as a substitute for safer sex practices or other prevention methods to reduce the risk of HIV transmission.